AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Spautin-1, an autophagy inhibitor which acts on Beclin-1 expression after inactivation of VSP34-AKT complexes, was shown to enhance Imatinib-induced primary CML cells apoptosis [31].